Evan L. Wasoff - Jan 27, 2022 Form 4 Insider Report for NEXIEN BIOPHARMA, INC. (NXEN)

Signature
Evan L. Wasoff
Stock symbol
NXEN
Transactions as of
Jan 27, 2022
Transactions value $
$0
Form type
4
Date filed
1/31/2022, 02:55 PM
Previous filing
Nov 29, 2021
Next filing
Sep 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXEN Common stock Award +250K +10% 2.75M Jan 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NXEN Options to purchase common stock (right to buy) 1.5M Jan 27, 2022 common stock 1.5M $0.08 Direct
holding NXEN Options to purchase common stock (right to buy) 420K Jan 27, 2022 common stock 420K $0.54 Direct
holding NXEN Options to purchase common stock (right to buy) 200K Jan 27, 2022 common stock 200K $0.66 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued in lieu of compensation for services.